Pretreatment with antithrombotic agents during radiofrequency catheter ablation: A randomized comparison of Aspirin Versus Ticlopidine

被引:22
作者
Manolis, AS
Maounis, T
Vassilikos, V
Melita-Manolis, H
Psarros, L
Terzoglou, G
Cokkinos, DV
机构
[1] Onassis Cardiac Surg Ctr, Athens, Greece
[2] Univ Patras, Patras, Greece
关键词
radiofrequency current; ablation; thrombosis; D-dimer; aspirin; ticlopidine;
D O I
10.1111/j.1540-8167.1998.tb00085.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: D-dimer is a product of fibrin degradation and can serve as a biochemical marker of thrombus formation and reactive fibrinolysis, According to our previous observations, and as reflected by elevated plasma D-dimer levels, lesions produced by radiofrequency (RF) ablation have a thrombogenic effect. Pretreatment with combined aspirin and ticlopidine mitigates this thrombogenicity; however, the effect of either agent alone remains unknown. Methods and Results: In this study, 59 patients undergoing RF ablation were randomized to pretreatment with aspirin (group I; n = 30) or ticlopidine (group II; n = 29) for 3 days prior to RF ablation. D-dimer levels were measured by enzyme immunoassay before and after the electrophysiologic study (EPS), and both immediately and at 48 hours after RF ablation, Results also were compared with those of 31 patients (nonrandomized group III) who had received both aspirin and ticlopidine. At all stages, D-dimer levels were higher in groups I and II when compared with group In. Baseline D-dimer (31 +/- 20 vs 24 +/- 13 vs 17 +/- 11 mu g/L, respectively; P = 0.002) rose after EPS to higher levels in groups I and II (91 +/- 100 mu g/L and 51 +/- 35 mu g/L) compared with group In (31 +/- 17 mu g/L; P = 0.001). After RF ablation, D-dimer levels increased in all groups, but this increase was much higher in groups I and II (214 +/- 210 mu g/L and 201 +/- 222 mu g /L) than in group III (74 +/- 60 mu g/L; P = 0.005). At 48 hours, D-dimer levels decreased in all groups, but remained higher in groups I and II (91 st 100 mu g/L and 95 +/- 99 mu g/L) than in group III (35 +/- 31 mu g/L; P = 0.009). There were no differences among the three groups in the number of RF ablation lesions or the duration of the RF ablation procedure, Conclusion: Pretreatment with aspirin or ticlopidine alone does not decrease the thrombogenic potential of RF ablation, Only combined therapy with aspirin and ticlopidine has a favorable effect, as reflected by the lower degree of D-dimer elevation.
引用
收藏
页码:1144 / 1151
页数:8
相关论文
共 20 条
[1]   RADIOFREQUENCY CATHETER ABLATION OF ACCESSORY ATRIOVENTRICULAR CONNECTIONS IN 250 PATIENTS - ABBREVIATED THERAPEUTIC APPROACH TO WOLFF-PARKINSON-WHITE SYNDROME [J].
CALKINS, H ;
LANGBERG, J ;
SOUSA, J ;
ELATASSI, R ;
LEON, A ;
KOU, W ;
KALBFLEISCH, S ;
MORADY, F .
CIRCULATION, 1992, 85 (04) :1337-1346
[2]   TRANSESOPHAGEAL ECHOCARDIOGRAPHIC EVALUATION FOR MURAL THROMBUS FOLLOWING RADIOFREQUENCY CATHETER ABLATION OF ACCESSORY PATHWAYS [J].
GOLI, VD ;
PRASAD, R ;
HAMILTON, K ;
MOULTON, KP ;
TYLER, M ;
LOGAN, P ;
LAZZARA, R ;
JACKMAN, WM .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1991, 14 (11) :1992-1997
[3]   Right and left atrial radiofrequency catheter therapy of paroxysmal atrial fibrillation [J].
Haissaguerre, M ;
Jais, P ;
Shah, DC ;
Gencel, L ;
Pradeau, V ;
Garrigues, S ;
Chouairi, S ;
Hocini, M ;
LeMetayer, P ;
Roudaut, R ;
Clementy, J .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 1996, 7 (12) :1132-1144
[4]   A randomized comparison of combined ticlopidine and aspirin therapy versus aspirin therapy alone after successful intravascular ultrasound-guided stent implantation [J].
Hall, P ;
Nakamura, S ;
Maiello, L ;
Itoh, A ;
Blengino, S ;
Martini, G ;
Ferraro, M ;
Colombo, A .
CIRCULATION, 1996, 93 (02) :215-222
[5]   THE MULTICENTER-EUROPEAN-RADIOFREQUENCY-SURVEY (MERFS) - COMPLICATIONS OF RADIOFREQUENCY CATHETER ABLATION OF ARRHYTHMIAS [J].
HINDRICKS, G ;
ALIOT, E ;
ALMENDRAL, JM ;
AMLIE, J ;
ARLOTTI, M ;
BARNAY, C ;
BASHIR, Y ;
BERGFELDT, L ;
BLANC, J ;
HIMBERT, J ;
THOMSEN, PEB ;
BLOMSTROMLUNDQVIST, C ;
BREMBILLAPERROT, B ;
BRUGADA, P ;
BRUGADA, J ;
COWAN, JC ;
CAUCHEMEZ, B ;
CLEMENTY, J ;
COBBE, S ;
CRITELLI, G ;
CRIJNS, H ;
DAUBERT, JC ;
DESOUSA, J ;
DJIANE, P ;
DONZEAU, JP ;
DUCKECK, W ;
EDWARDSSON, N ;
FARRE, J ;
COSNAY, P ;
FONTAINE, G ;
FROMER, M ;
GOICOLEA, A ;
GONSKA, BD ;
GROLLEAURAOUX, R ;
HAISSAGUERRE, M ;
HAVERKAMP, W ;
HERMIDA, JS ;
HIEF, C ;
HOPP, HW ;
HOFFMAN, E ;
HUIKURI, H ;
JORDAENS, L ;
KALUSCHE, D ;
KUHLKAMP, V ;
LAUCEVICIUS, A ;
LAVERGNE, T ;
MANZ, M ;
MOLLER, M ;
MONT, L ;
NATHAN, AW .
EUROPEAN HEART JOURNAL, 1993, 14 (12) :1644-1653
[6]   ROLE OF RADIOFREQUENCY ABLATION IN THE MANAGEMENT OF SUPRAVENTRICULAR ARRHYTHMIAS - EXPERIENCE IN 760 CONSECUTIVE PATIENTS [J].
KAY, GN ;
EPSTEIN, AE ;
DAILEY, SM ;
PLUMB, VJ .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 1993, 4 (04) :371-389
[7]   RADIOFREQUENCY CURRENT CATHETER ABLATION OF ACCESSORY ATRIOVENTRICULAR PATHWAYS [J].
KUCK, KH ;
SCHLUTER, M ;
GEIGER, M ;
SIEBELS, J ;
DUCKECK, W .
LANCET, 1991, 337 (8757) :1557-1561
[8]   CURATIVE PERCUTANEOUS CATHETER ABLATION USING RADIOFREQUENCY ENERGY FOR ACCESSORY PATHWAYS IN ALL LOCATIONS - RESULTS IN 100 CONSECUTIVE PATIENTS [J].
LESH, MD ;
VANHARE, GF ;
SCHAMP, DJ ;
CHIEN, W ;
LEE, MA ;
GRIFFIN, JC ;
LANGBERG, JJ ;
COHEN, TJ ;
LURIE, KG ;
SCHEINMAN, MM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992, 19 (06) :1303-1309
[9]   Thrombogenicity of radiofrequency lesions: Results with serial D-dimer determinations [J].
Manolis, AS ;
MelitaManolis, H ;
Vassilikos, V ;
Maounis, T ;
Chiladakis, J ;
ChristopoulouCokkinou, V ;
Cokkinos, DV .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 28 (05) :1257-1261
[10]   RADIOFREQUENCY ABLATION OF SLOW PATHWAY IN PATIENTS WITH ATRIOVENTRICULAR NODAL REENTRANT TACHYCARDIA - DO ARRHYTHMIA RECURRENCES CORRELATE WITH PERSISTENT SLEW PATHWAY CONDUCTION OR SITE OF SUCCESSFUL ABLATION [J].
MANOLIS, AS ;
WANG, PJ ;
ESTES, NAM .
CIRCULATION, 1994, 90 (06) :2815-2819